In the Phase 3 open-label extension clinical trial (OLE), patients with moderate to severe acne received denifanstat for up ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...
Researchers at WashU Medicine have received an $11.7 million grant from the National Heart, Lung, and Blood Institute of the ...
KIT2014 is a novel inhaled peptide therapy being developed for respiratory diseases including chronic obstructive pulmonary ...
BACKGROUND: Epigenetic mechanisms underlying susceptibility to abdominal aortic aneurysm (AAA) remain poorly understood.
The study, published in Frontiers in Immunology, was conducted by researchers from Hofstra University and Northwell Health in ...
Engineered Cell Therapies, Solid Tumors, and the Future of Pediatric Immunotherapy / Acute Lymphoblastic Leukemia, Acute ...
Once the preserve of sailors, bikers and rock stars, body art has become so mainstream that it now adorns the skin of ...
After identifying a novel population of innate lymphoid cells in the gut, Gregory Sonnenberg set out to characterize these ...
Watching an NHK program about depression, something bothered me a little.It seems research is progressing on the idea that ...
Why the Term "Tendinitis" Is No Longer UsedTendon pain was once called "tendinitis" and was thought to be caused by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results